Day at the Races: Comparing BioFire FilmArray Blood Culture ID Panels With Verigene Blood Culture Panel in Gram-Negative Bloodstream Infections Using DOOR-MAT Analysis.

Kimberly C ClaeysKathryn SchlafferRichard SmithStephanie HitchcockYunyun JiangScott EvansJ Kristie JohnsonSurbhi Leekha

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)

Three rapid diagnostic test panels (Verigene BC-GN, BioFire BCID, and BCID 2 [RUO]) were compared using the Desirability of Outcome Ranking Management of Antimicrobial Therapy (DOOR-MAT) to evaluate potential downstream antimicrobial prescribing decisions resulting from the panels' different organism and resistance detection. BioFire BCID 2 (RUO) had the best mean DOOR-MAT scores.

Keyphrases

gram negative
multidrug resistant
loop mediated isothermal amplification
staphylococcus aureus
primary care
emergency department
stem cells
human health
label free
mesenchymal stem cells
risk assessment
adverse drug
sensitive detection
real time pcr
cell therapy